Tag Archives: Mike Catalano

Courtagen-Life-sciences

Courtagen Receives Notice of Allowance for a Genetically Targeted Pain Therapy Patent in the U.S.

Courtagen Receives Notice of Allowance for a Genetically Targeted Pain Therapy Patent in the U.S.

WOBURN, Mass., Feb. 23, 2017 /Weed Wire/ — Courtagen Life Sciences, Inc., an innovative endocannabinoid platform and molecular information company, announced today that the company has received a Notice of Allowance from the United States Patent and Trademark Office for its patent application no. 14/895,557, titled “Methods and Kits for Treating and Classifying Individuals at Risk of or Suffering from TRAP1 Change-of-Function.”

CannMed 2017

CannMed 2017 Conference Announces Expanded Speaker List for Medical Cannabis Health and Research Conference to be Held in Boston in April

WOBURN, Mass., Feb. 10, 2017 /Weed Wire/ — Medicinal Genomics and Courtagen Life Sciences, today announced an increasingly influential speaker lineup for CannMed 2017.

Medicinal Genomics Receives NIDA Grant to Develop Novel Toxin Detection Test for Medical Cannabis

WOBURN, Mass., Jan. 25, 2017 /Weed Wire/ — Medicinal Genomics (MGC) and Courtagen Life Sciences today announced that the National Institute on Drug Abuse (NIDA) has awarded the company an SBIR Phase I grant to develop a novel test to detect toxins resulting from microbiological contamination of medical cannabis.

Courtagen-Life-sciences

CannMed 2017 Conference to Offer Doctors an Opportunity to Earn CME Credits to Learn about Cannabis Medicine

WOBURN, Mass., Jan. 12, 2017 /Weed Wire/ — Courtagen Life Sciences and Medicinal Genomics today announced a partnership with TheAnswerPage.com to provide continuing medical education (CME) credits to physicians and other healthcare professionals for the upcoming CannMed 2017 Personalized Cannabinoid Medicine Conference


Top